| PERIOD ENDING | 3-Apr-09 | 31-Dec-08 | 26-Sep-08 | 27-Jun-08 | | Total Revenue | 2,627,744 | 3,176,506 | 3,208,181 | 3,283,895 | | Cost of Revenue | 1,369,135 | 1,724,897 | 1,697,611 | 1,723,596 | | | Gross Profit | 1,258,609 | 1,451,609 | 1,510,570 | 1,560,299 | | | Operating Expenses | | Research Development | 160,895 | 167,467 | 182,006 | 189,866 | | Selling General and Administrative | 757,495 | 860,491 | 806,424 | 859,969 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 340,219 | 423,651 | 522,140 | 510,464 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 665 | 4,000 | 1,070 | 1,412 | | Earnings Before Interest And Taxes | 340,884 | 427,651 | 523,210 | 511,876 | | Interest Expense | 24,057 | 25,433 | 30,218 | 33,854 | | Income Before Tax | 316,827 | 402,218 | 492,992 | 478,022 | | Income Tax Expense | 79,115 | 96,532 | 121,000 | 114,574 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 237,712 | 305,686 | 371,992 | 363,448 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 237,712 | 305,686 | 371,992 | 363,448 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $237,712 | $305,686 | $371,992 | $363,448 |
|
0.45% Nasdaq 
0.20%
Income Statement
